Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAPOLI-2: Phase II Study of Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Previously Treated Advanced Biliary Tract Cancer

NCT04005339 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT04005339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAPOLI-2: Phase II Study of Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Previously Treated Advanced Biliary Tract Cancer
Lead sponsor
Georgetown University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 29, 2019
Completion date
December 31, 2026
Enrollment
48 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced biliary tract cancer